Search Within

Hijin Angela Park

Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
  3. Book Section (1)
  4. Correspondence (1)
Groups
  1. Radiochemistry and Imaging Sciences Service (8)
  2. Radiology, Department of (8)
  3. GSK Faculty (7)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  5. Center for Pancreatic Cancer Research (4)
  6. Department of Medicine (4)

More Groups

People
  1. Serge Lyashchenko (8)
  2. Andrea Knezevic (3)
  3. Darren Feldman (3)
  4. Jason Lewis (3)
  5. Martin Voss (3)
  6. Neeta Pandit-Taskar (3)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
  5. 2019 (2)
Publications
  1. Journal of Clinical Oncology (3)
  2. Nuclear Medicine and Biology (2)
  3. Journal of Magnetic Resonance Imaging (1)
  4. Journal of Nuclear Medicine (1)
  5. Nuclear Medicine and Molecular Imaging (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Elsevier Science Inc. (2)
  3. Elsevier Inc. (1)
  4. Society of Nuclear Medicine (1)
  5. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Assessment of the feasibility of hyperpolarized [1-(13)C] pyruvate whole-abdomen MRI using D(2)O solvation in humans
    Correspondence

    Zhang, G.; Deh, K.; Park, H.; Cunningham, C. H.; Bragagnolo, N. D.; Lyashchenko, S.; Ahmmed, S.; Leftin, A.; Coffee, E.; Kelsen, D.; more...
    Journal of Magnetic Resonance Imaging (2024)

    Fulltext@MSK | Save
  • [(89)Zr]ZrCl(4) for direct radiolabeling of DOTA-based precursors
    Journal Article

    Lyashchenko, S. K.; Tran, T.; Happel, S.; Park, H.; Bauer, D.; Jones, K.; Esposito, T. V.; Pillarsetty, N.; Lewis, J. S.
    Nuclear Medicine and Biology (2024)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti–carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Performance of clinical trials with radiopharmaceuticals in the United States
    Book Section

    Lyashchenko, S. K.; Vietri, S. M.; Park, H. A.; Kourlas, G.
    In Signore, A. (Eds.) Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)Lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A rapid bead based radioimmunoassay for the determination of target binding fraction and quality control of radiopharmaceuticals
    Meeting Abstract

    Sharma, S. K.; Lyashchenko, S.; Park, H.; Roux, Y.; Pillarsetty, N. V. K.; Poty, S.; Tully, K.; Poirier, J.; Lewis, J.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals
    Journal Article

    Sharma, S. K.; Lyashchenko, S. K.; Park, H. A.; Pillarsetty, N.; Roux, Y.; Wu, J.; Poty, S.; Tully, K. M.; Poirier, J. T.; Lewis, J. S.
    Nuclear Medicine and Biology (2019)

    Fulltext@MSK | Save